Experimental pancreatic cancer drug nearly doubles survival in Phase 3 trial
A new experimental drug for metastatic pancreatic cancer nearly doubled overall survival in a pivotal...
Original Source
Read the full article at Interestingengineering →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.